Apoptosis prevention as a mechanism of immune evasion

被引:25
|
作者
Aubert, M
Jerome, KR
机构
[1] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98125 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
关键词
apoptosis; virus; cytotoxic lymphocyte; antigen presentation; danger signal; innate immunity;
D O I
10.1080/08830180305213
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
When cells are infected with viruses, they may trigger their apoptosis programs. In unicellular organisms, this may have protected cell populations by limiting viral replication from infected cells. Multicellular organisms can also trigger the apoptosis program after viral infection. In response, viruses have evolved a wide variety of inhibitors of apoptosis. In higher organisms, the outcome of viral infections is largely determined by the immune system. Since apoptosis is intimately linked to the function and regulation of the immune system, the ability of viruses to inhibit apoptosis could profoundly alter the immune response. Viral antiapoptotic proteins could protect infected cells from apoptosis induced by cytotoxic lymphocytes, alter antigen cross-presentation and the priming of the immune response, or modulate the expression of danger signals from sites of infection. The virus/host interaction is likely to provide useful lessons regarding the workings of the mammalian immune system.
引用
收藏
页码:361 / 371
页数:11
相关论文
共 50 条
  • [41] Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis
    Timmer, Anjuli M.
    Timmer, John C.
    Pence, Morgan A.
    Hsu, Li-Chung
    Ghochani, Mariam
    Frey, Terrence G.
    Karin, Michael
    Salvesen, Guy S.
    Nizet, Victor
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (02) : 862 - 871
  • [42] Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention
    Yang, Betsy
    Yang, Kuender D.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Epidemiology, pathogenesis, immune evasion mechanism and vaccine development of porcine Deltacoronavirus
    Shan, Xueting
    Li, Rui
    Ma, Xiang
    Qiu, Guoqiang
    Xiang, Yi
    Zhang, Xiaojun
    Wu, De
    Wang, Lu
    Zhang, Jianhong
    Wang, Tao
    Li, Weifen
    Xiang, Yun
    Song, Houhui
    Niu, Dong
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (03)
  • [44] Fas counterattack in cholangiocarcinoma: a mechanism for immune evasion in human hilar cholangiocarcinomas
    Li, ZY
    Zou, SQ
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (06) : 860 - 863
  • [45] RNA Virus Reassortment: An Evolutionary Mechanism for Host Jumps and Immune Evasion
    Vijaykrishna, Dhanasekaran
    Mukerji, Reshmi
    Smith, Gavin J. D.
    PLOS PATHOGENS, 2015, 11 (07)
  • [46] EXPRESSION OF FLIP IN HUMAN COLON CARCINOMAS: A NEW MECHANISM OF IMMUNE EVASION
    邢宝才
    S. Wimmenauer
    EH. Farthmann
    Chinese Journal of Cancer Research, 2005, (03) : 193 - 198
  • [47] Structure of anellovirus-like particles reveal a mechanism for immune evasion
    Liou, Shu-hao
    Boggavarapu, Rajendra
    Cohen, Noah R.
    Zhang, Yue
    Sharma, Ishwari
    Zeheb, Lynn
    Mukund Acharekar, Nidhi
    Rodgers, Hillary D.
    Islam, Saadman
    Pitts, Jared
    Arze, Cesar
    Swaminathan, Harish
    Yozwiak, Nathan
    Ong, Tuyen
    Hajjar, Roger J.
    Chang, Yong
    Swanson, Kurt A.
    Delagrave, Simon
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [48] Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion
    Mitsiades, N
    Poulaki, V
    Mastorakos, G
    Tseleni-Balafouta, S
    Kotoula, V
    Koutras, DA
    Tsokos, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08): : 2924 - 2932
  • [49] The epithelial Fas counterattack: Potential mechanism for tumor-immune evasion
    OConnell, J
    Bennett, B
    Kelly, J
    OSullivan, O
    Collins, JK
    Shanahan, F
    GASTROENTEROLOGY, 1997, 112 (04) : A1053 - A1053
  • [50] IFNAR1 Degradation: A New Mechanism for Tumor Immune Evasion?
    Araya, Romina E.
    Goldszmid, Romina S.
    CANCER CELL, 2017, 31 (02) : 161 - 163